Szpunar, Mercedes J <br/><br/>
The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure.  [electronic resource] 

 -  Cancer prevention research (Philadelphia, Pa.)  Dec 2013 
 - 1262-72 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1940-6215 
<br/><br/><label>Standard No.: </label>10.1158/1940-6207.CAPR-13-0079  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Adrenergic alpha-2 Receptor Agonists--pharmacology<br/>Animals<br/>Antidepressive Agents, Tricyclic--pharmacology<br/>Apoptosis<br/>Breast Neoplasms--drug therapy<br/>Cell Proliferation<br/>Collagen--chemistry<br/>Cytokines--metabolism<br/>Desipramine--pharmacology<br/>Dexmedetomidine--pharmacology<br/>Disease Progression<br/>Female<br/>Humans<br/>Image Processing, Computer-Assisted<br/>Immunoenzyme Techniques<br/>Lung Neoplasms--drug therapy<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Nude<br/>Microscopy, Fluorescence, Multiphoton<br/>Norepinephrine--metabolism<br/>Receptors, Adrenergic, alpha-2--metabolism<br/>Tumor Cells, Cultured